D
David Cohen
Researcher at Pierre-and-Marie-Curie University
Publications - 787
Citations - 45536
David Cohen is an academic researcher from Pierre-and-Marie-Curie University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 83, co-authored 635 publications receiving 37722 citations. Previous affiliations of David Cohen include University of California, Berkeley & University of Michigan.
Papers
More filters
Journal ArticleDOI
EP197/#293 Endometrial cancer recurrences in the era of COVID
Jenna Patterson,Courtney J. Riedinger,Floor J. Backes,David M. O'Malley,Kristin Bixel,Larry J. Copeland,David Cohen,P B Goodfellow,Casey M. Cosgrove +8 more
TL;DR: In this article , the clinical presentation of EC recurrence did not change in the population after COVID, suggesting that health care adaptations utilized during the pandemic, including telemedicine, warrant further investigation.
Journal ArticleDOI
Carboplatin dosing in the treatment of ovarian cancer: An NRG oncology group study.
Aaron M. Praiss,Austin Miller,Judith Smith,Stuart M. Lichtman,Michael A. Bookman,Carol Aghajanian,Paul Sabbatini,Floor J. Backes,David Cohen,Peter A. Argenta,Michael Friedlander,Michael J. Goodheart,David G. Mutch,David M. Gershenson,Krishnansu S. Tewari,Robert M. Wenham,Andrea E. Wahner Hendrickson,Roger B. Lee,Heidi J. Gray,Angeles Alvarez Secord,Linda Van Le,Roisin E. O'Cearbhaill +21 more
TL;DR: In this paper , the effects of using National Comprehensive Cancer Network (NCCN) guidelines to estimate renal function on carboplatin dosing and explore adverse effects associated with a more accurate estimation of lower creatinine clearance (CrCl).
Journal ArticleDOI
Is variety really the spice of life? An NCDB analysis of treatment patterns of stage IB grade 3 endometrioid endometrial carcinoma (192)
TL;DR: In this article , the authors used multivariable-adjusted logistic regression to estimate odds ratios (ORs and 95% confidence intervals (CIs) for associations of demographic and tumor characteristics with the type of adjuvant treatment received (surgery only, radiation only [RT], or chemotherapy +/- radiation [chemo +/- RT]).
Journal ArticleDOI
Glassy cell carcinoma of the cervix: Findings from a combined National Cancer Database analysis and single institution review of treatment patterns and outcomes.
Monica D. Levine,David A. Barrington,Caitlin E Meade,Sydney M. Lammers,Eric McLaughlin,Adrian A. Suarez,Floor J. Backes,Larry J. Copeland,David M. O'Malley,Casey M. Cosgrove,David Cohen,Christa Nagel,Ashley S. Felix,Kristin Bixel +13 more
TL;DR: In this article , the authors described stage, treatment patterns, and survival for glassy cell carcinoma of the cervix (GCCC), a poorly understood rare tumor, and performed clinical data and survival analyses for early-stage and locally-advanced cases.